India’s largest rubber chemicals maker, NOCIL Ltd, just rolled into Q1 FY26 with all the grace of a punctured scooter. Sales dipped 9.7% YoY to ₹336 Cr, profits collapsed 36% YoY to ₹17 Cr, and margins barely clung to single digits (9%). Market cap? A not-so-glamorous ₹3,125 Cr. For a company with a 40% domestic market share, NOCIL looks less like Michelin and more like your neighbourhood tyre repair shop — always busy, never rich.
2. Introduction
Born in 1961, part of the Arvind Mafatlal Group, NOCIL is India’s chemical sidekick to the tyre industry. If MRF, Apollo, and CEAT are the Bollywood heroes zooming down the highway, NOCIL is the guy handing them the “Pilcure” magic potion so their rubber doesn’t fall apart.
On paper, it should be unstoppable: market leader, entry barriers galore, approvals that take 6–18 months (slower than Indian courts), and export footprint across 40 countries. Yet, the stock has fallen 35% in the last year. Why? Because demand is squishy, exports are weak, and margins behave like India’s monsoon — heavy one year, a drought the next.
Q1 FY26 was no exception: operating capacity stuck at ~65%, profit margins eroding faster than a Mumbai road in July, and global rubber demand flatter than a dosa. But management insists that expansions at Dahej and new export orders will kick-start growth. Until then, investors are left with dividend crumbs (34% payout) and the hope that tyres don’t go out of fashion.
3. Business Model – WTF Do They Even Do?
NOCIL is basically a chemist for rubber. Its products fall into three families:
Accelerators – speed up vulcanisation (like Red Bull for rubber).
Anti-degradants / Antioxidants – keep tyres from dying early (basically, chemical Botox).
Exports: 33% (to 40 countries, though mostly ASEAN, EU, US).
Narrator’s Roast: So NOCIL sells the chemical masala that ensures your Ola tyre doesn’t burst in the first pothole. Yet somehow, the guy selling masala is poorer than the guy frying pakoras.
4. Financials Overview
Metric
Latest Qtr (Q1 FY26)
YoY Qtr (Q1 FY25)
Prev Qtr (Q4 FY25)
YoY %
QoQ %
Revenue
336 Cr
372 Cr
340 Cr
-9.7%
-1.2%
EBITDA
31 Cr
41 Cr
34 Cr
-24.4%
-8.8%
PAT
17 Cr
27 Cr
21 Cr
-36.2%
-19.0%
EPS (₹)
1.03
1.62
1.24
-36.4%
-17.0%
Commentary: Sales skid, profits burst a tyre, and EPS fell harder than Hero Honda resale values. This is not “accelerated growth,” it’s “accelerated erosion.”